Is prophylactic cranial irradiation a possible option for human epidermal growth factor receptor 2-positive breast cancer?

被引：2
|
作者：
Buyukhatipoglu, Hakan [1 ]
Sevinc, Alper [1 ]
Pehlivan, Yavuz [1 ]
Camci, Celalettin [1 ]
机构：
[1] Gaziantep Univ, Gaziantep Oncol Hosp, Sch Med, Gaziantep, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 10期
关键词：
D O I：
10.1200/JCO.2006.10.1253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1292 / 1292
页数：1
相关论文
共 50 条
  • [41] Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer
    Yu, Ke-Da
    Zhou, Zhi-Rui
    Shao, Zhi-Ming
    CANCER RESEARCH, 2020, 80 (04)
  • [42] Human epidermal growth factor receptor 2-positive digestive tumors
    Wagner, Anna D.
    Ozdemir, Berna C.
    Rueschoff, Josef
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (04) : 354 - 361
  • [43] Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer
    Lv, Huimin
    Yan, Min
    Jiang, Zefei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [44] Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Bloom, Meghan J.
    Song, Patrick N.
    Virostko, John
    Yankeelov, Thomas E.
    Sorace, Anna G.
    CANCERS, 2022, 14 (17)
  • [45] Optimizing Therapy to Match the Risk: Neoadjuvant Approaches to Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Thomas, Alexandra
    Broderick, Amanda
    Anders, Carey K.
    JCO ONCOLOGY PRACTICE, 2024, 20 (08)
  • [46] Chemotherapy Agents in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Time to Step Out of the Limelight
    Lin, Nancy U.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) : 251 - 253
  • [47] GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
    Rizzi, Anna
    Aroldi, Francesca
    Bertocchi, Paola
    Prochilo, Tiziana
    Mutti, Stefano
    Savelli, Giordano
    Fraccon, Anna Paola
    Zaniboni, Alberto
    CHEMOTHERAPY, 2017, 62 (01) : 30 - 33
  • [48] Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer
    Giachetti, Pier Paolo M. Berton
    Giordano, Elisa
    Salimbeni, Beatrice Taurelli
    Trapani, Dario
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (06) : 480 - 486
  • [49] Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: An Integrated Safety Analysis
    Dieras, Veronique
    Harbeck, Nadia
    Budd, G. Thomas
    Greenson, Joel K.
    Guardino, Alice E.
    Samant, Meghna
    Chernyukhin, Nataliya
    Smitt, Melanie C.
    Krop, Ian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2750 - +
  • [50] Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer
    Schwartz, Naomi R. M.
    DeBusk, Kendra
    Forero-Torres, Andres
    Feliciano, Joseph
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    McBride, Ali
    FUTURE ONCOLOGY, 2021, 17 (26) : 3457 - 3464
12345